Home 
Bratislava Medical Journal 2022 Bratislava Medical Journal Vol.123, No.5, p.347–351, 2022
Bratislava Medical Journal 2022 Bratislava Medical Journal Vol.123, No.5, p.347–351, 2022
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.123, No.5, p.347–351, 2022 |
||
| Title: The plasma level of glutamic acid decarboxylase 65 (GAD65) increased in severely autistic Iranian children | ||
| Author: Somayeh VAZIFEKHAH, Shahram BARFI, Fatemeh SOLEIMANY, Amirhossein ALIAKBAR, Fahime Zavvari, Fariba KARIMZADEH | ||
| Abstract: INTRODUCTION: Autism spectrum disorder (ASD) is a neurodevelopmental disorder. The major etiological mechanism lies in glutamatergic/GABAergic imbalance. The aim of this study was to evaluate the plasma levels of glutamic acid decarboxylase 65 (GAD65) protein in mildly and severely autistic patients, and also to compare plasma GAD65 concentration in mild and severe autism. METHOD: In total, 62 autistic patients (aged 6–9 years) and 17 age-matched neurotypically healthy controls were included in the study. The diagnosis, as well as the level of autism, was assessed by applying the Gilliam Autism Rating Scale. Plasma GAD65 protein level was determined using an enzyme-linked immunosorbent assay (ELISA) kit for GAD65. RESULTS: Our findings showed no remarkable alteration in plasma GAD65 concentration in patients with mild autism as compared to healthy subjects, while patients with severe autism showed an increased plasma level of GAD65 as compared to healthy controls and mildly autistic patients. CONCLUSION: Our findings suggest the level of plasma GAD65 to be considered a potential diagnostic biomarker for the severity of autism (Fig. 2, Ref. 40). |
||
| Keywords: autism, GAD65, GABA, plasma level, biomarker | ||
| Published online: 14-Apr-2022 | ||
| Year: 2022, Volume: 123, Issue: 5 | Page From: 347, Page To: 351 | |
| doi:10.4149/BLL_2022_054 |
||
|
|
 download file |
|